EUVIMEDEUVIMED entdecken
Open Access

Insulin Receptor Family Autoantibodies in Patients with Type B Insulin Resistance

Jennifer E Lee, Thilo S Chillon, Waldemar B Minich, Brent S Abel, Marissa Lightbourne, Lutz Schomburg iD, Rebecca J Brown iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Jennifer E Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Autoantibodies, Insulin Resistance, Receptor, Insulin, Antigens, CD. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: German Federal Ministry of Economics and Technology, NIDDK NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Type B insulin resistance (TBIR) is a rare autoimmune disorder characterized by insulin resistance (IR) secondary to insulin receptor autoantibodies (InsR-aAb). A paucity of clinical InsR-aAb assays and incomplete mechanistic understanding complicate diagnosis.

Objective

This study aimed to (1) validate clinical performance of an immune-luminometric InsR-aAb assay in a relatively large cohort; (2) evaluate its diagnostic accuracy and define thresholds for TBIR diagnosis; and (3) evaluate autoantibody profiles against InsR, type 1 IGF receptor (IGF-1R), and the insulin receptor-related receptor (IRRR) in TBIR and non-autoimmune IR.

Methods

We conducted a cross-sectional analysis of patients with TBIR and non-autoimmune IR. InsR-aAb, IGF-1R-aAb, and IRRR-aAb titers were measured using receptor-specific immune-luminometric assays. Receiver operating characteristic analyses assessed diagnostic performance of the InsR-aAb assay. Multivariate regression models evaluated associations between autoantibody titers and biomarkers of glycemia (glycated hemoglobin [HbA1c], glucose, insulin), growth (IGF-1 z-score [IGF-1z]), and pH regulation (bicarbonate, urine pH).

Results

In TBIR, higher InsR-aAb titers associated with increased HbA1c, glucose, insulin, and lower IGF-1z (all P < .0001); higher IRRR-aAb titers with lower CO2 (P = .04). An optimal InsR-aAb cutoff for distinguishing TBIR from non-autoimmune IR was determined (area under the curve [AUC] 0.96, sensitivity 91.3%, specificity 93.9%). In non-autoimmune IR, autoantibody titers were not associated with glycemia biomarkers; IGF-1z increased with mild IR (P = .005) and decreased with severe IR (P = .01).

Conclusion

This study validates an InsR-aAb assay in the largest TBIR cohort to date and identifies a novel association between IRRR-aAb and bicarbonate excretion. While InsR-aAb were detected in other IR disorders, pathogenic effects were specific to TBIR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesInsulin ResistanceReceptor, InsulinAntigens, CDHumansFemaleMaleCross-Sectional StudiesMiddle AgedBiomarkersAdultReceptor, IGF Type 1

Stichwörter der Autor:innen

assayshyperglycemiahypoglycemiain vitro diagnosisuncontrolled diabetes

Substanzen

AutoantibodiesReceptor, InsulinAntigens, CDBiomarkersINSR protein, humanReceptor, IGF Type 1

Autor:innen und Institutionen

  • National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Institute for Experimental Endocrinology, Charité-Universitätsmedizin Berlin, Berlin D-10115, Germany.
  • Department of Clinical Biochemistry, Odense University Hospital, Odense 5000, Denmark.

ORCID-Profile: Lutz Schomburg, Rebecca J Brown

Förderung

  • German Federal Ministry of Economics and Technology
  • NIDDK NIH HHS
  • NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institutes of Health

Zitieren

APA

Lee, J. E., Chillon, T. S., Minich, W. B., Abel, B. S., Lightbourne, M., Schomburg, L., & Brown, R. J. (2026). Insulin Receptor Family Autoantibodies in Patients with Type B Insulin Resistance. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf692

Vancouver

Lee JE, Chillon TS, Minich WB, Abel BS, Lightbourne M, Schomburg L, et al. Insulin Receptor Family Autoantibodies in Patients with Type B Insulin Resistance. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf692

BibTeX
@article{Lee2026,
  author = {Lee, Jennifer E and Chillon, Thilo S and Minich, Waldemar B and Abel, Brent S and Lightbourne, Marissa and Schomburg, Lutz and Brown, Rebecca J},
  title = {Insulin Receptor Family Autoantibodies in Patients with Type B Insulin Resistance},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf692}
}
Kostenlos starten →